Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of KBP-5074 Following Oral Administration in Chronic Kidney Disease [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, and pharmacokinetics of oral KBP-5074 in adults with chronic kidney disease; results have been completed and poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• KBP-5074 (KBP-5074)

Snippet

Sponsor: KBP Biosciences | Conditions: Chronic Kidney Disease | Phase 1 | Status: COMPLETED | Results posted: 2019-10-15